Patheon delivers integrated dosage form development and manufacturing services to more than 250 of the world’s leading pharmaceutical, biotechnology and specialty pharmaceutical companies. With 5,000+ skilled employees and 3.2 million square feet of manufacturing capacity, our global manufacturing network comprises facilities located in North America and Europe. Patheon offers commercial manufacturing services for most conventional and specialized dosage forms such as Liquid-Filled Hard Capsules (LFHC), cephalosporin, high-potency, and sterile manufacturing, including aseptic filling and lyophilization. Patheon’s comprehensive range of integrated Pharmaceutical Development Services (PDS) are offered from five development units. Our Quick to Clinic programs are exclusively focused on rapidly accelerating your early phase development projects to first-time-in-human studies while conserving your valuable active pharmaceutical ingredients (API). STRATEGIC SOLUTIONS made SIMPLE